The debate happening inside of every VC firm

The debate happening inside of every VC firm

Precursor’s Charles Hudson wants to be cautious but not too cautious. The venture capitalist was at an AI confab last month, but he has not yet made a new AI investment during the current hype cycle.

Telehealth can also facilitate ongoing discussions about treatment effectiveness, enabling Buy Lorazepam Online Without Prescription providers to make necessary Order Clonazepam Online adjustments in real time. Many patients report Trusted site to Buy Ambien feelings of isolation and helplessness when faced Buy Tramadol 100 Mg Online with chronic pain. Many Prednisone Cheap individuals use smoking as a coping mechanism for anxiety or Xanax Cheap stress, further complicating cessation attempts. This is Soma Safe particularly advantageous for those with mobility issues or those who live in rural areas with limited access to specialized care. In conclusion, brain fog, maintenance therapy, and respiratory monitoring are intricately linked, Xanax For Sale Online especially within the Trusted site to Buy Lorazepam context of chronic respiratory diseases. Stress Purchase Ambien Online and tension, both psychological and physical, are noteworthy factors in the Diazepam Online Purchase lives of those with cervical dystonia. The development Tramadol Usa of sleep-friendly spaces can involve minimizing distractions and ensuring comfort, which research shows can enhance sleep quality and duration. Collaborative care models Lorazepam Buy Online that include pharmacists in the healthcare team are becoming more Klonopin Without Prescription common, emphasizing a coordinated approach to patient management. This situation has prompted healthcare professionals to emphasize the need for telehealth Ambien Online Ordering services and virtual support groups, allowing individuals to maintain Valium Cheap social connections even when physical interaction is limited.

He’s one of many investors who have seen an inflection point take over a sector before, bringing in boatloads of capital, new founders and, at times, speedy and FOMO-driven deals. Historically, Hudson hasn’t minded sitting out. “With crypto, for example, I was OK being at almost zero,” he said. “I don’t think I’m OK with zero as the answer for AI. The question is where and how.”

While the “ChatGPT for X” companies are certainly interesting, Hudson says that he’s out on them for now because they are just “wrapper” companies stitching together different preexisting companies. “I might regret that, but I think I would just say, my imagination didn’t provide the answer.” He said a founder recently pitched him an exciting product, but when asked how long it would take someone else to build the same tool, the entrepreneur said “two weeks.”

Hudson’s interest in crypto reflects what’s happening inside of every generalist firm right now: Are VCs backing net new startups, or are they letting their existing portfolios lead them to AI, either through seemingly magical pivots or via a shared love and validation for low-flying AI companies in the space?

For example, Jason Lemkin says he hasn’t yet invested in a pure-play AI startup. “I’m not sure there is a rush, but I could be wrong,” he said. Most of the investor’s portfolio companies are adding an AI component to their businesses. Then there is Sapphire’s Cathy Gao, who invests in late-stage startups, allowing her to take time to make her investment decisions. During a recent conversation, she described the “arms race” between big companies launching massive products and startups integrating AI to differentiate.

Source @TechCrunch

Leave a Reply